Endoscopic and surgical evaluation of epiphora in children with Down syndrome

Jutaro Nakamura1, Mizuki Asano2, Tomoko Ohno3

  • 1Department of Ophthalmology and Visual Science, Yokohama City, University Graduate School of Medicine, Yokohama, Japan; Department of Ophthalmology, Kanagawa Children's Medical Center, Yokohama, Japan.

Insights

Primary epiphora in Down syndrome (DS) patients often involves chronic inflammation and developmental anomalies. Surgical interventions like probing or endoluminal lacrimal duct recanalization (ELDR) provide only partial symptom relief in most cases.

Area of Science:

  • Ophthalmology
  • Genetics
  • Pediatric Surgery

Background:

  • Down syndrome (DS) is associated with various congenital anomalies, including potential issues within the nasolacrimal drainage system.
  • Primary epiphora, or excessive tearing, can significantly impact the quality of life for affected individuals, particularly children.

Purpose of the Study:

  • To investigate the clinical features and surgical results for primary epiphora in patients with Down syndrome.
  • To analyze the effectiveness of different surgical interventions for epiphora in this specific population.

Main Methods:

  • Retrospective review of medical records for 63 children with Down syndrome and primary epiphora treated at a tertiary pediatric hospital (2013-2023).
  • Analysis included clinical characteristics, diagnostic findings (lacrimal syringing, dacryoendoscopy), and surgical outcomes (probing, endoluminal lacrimal duct recanalization with stent intubation).

Main Results:

  • Epiphora was congenital in 67% of patients; 70% had passage on lacrimal syringing, while 30% showed obstruction.
  • Eighteen patients underwent surgery, with complete resolution in 7 (39%), partial resolution in 10 (56%), and failure in 1 (5%).
  • Dacryoendoscopy identified dense fibrous tissue, suggesting chronic inflammation, as a cause of obstruction in several cases.

Conclusions:

  • Dacryoendoscopy revealed stenotic lacrimal passages due to developmental anomalies and chronic inflammatory fibrous obstruction in DS patients with epiphora.
  • Surgical interventions (probing or ELDR) yielded only partial symptom improvement in approximately two-thirds of patients, indicating limited efficacy for complete resolution.
Abstract